Results for
"[search-keyword]"
Sponsor content
339 result(s) found, displaying 61 to 70
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe.
-
Prescription medicine registrationActive ingredients: belzutifan.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Australian Public Assessment Report (AusPAR)AusPAR for Vaxneuvance (pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed) for the prevention of pneumococcal disease.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd